Holler A, Zech M, Ghorashian S, Pike R, Hotblack A, Veliça P, Xue S-A, Chakraverty R, Morris EC, Stauss HJ. Expression of a dominant T-cell receptor can reduce toxicity and enhance tumor protection of allogeneic T-cell therapy. Haematologica 2016; 101(4):482-490; https://doi.org/10.3324/haematol.2015.132712.